Reinhold Kreutz

Professor Kreutz is a full Professor of Clinical Pharmacology and Hypertensiology and the Director of the Department of Clinical Pharmacology and Toxicology at Charité – Universitätsmedizin Berlin, Germany. He is Past President of the European Society of Hypertension (ESH). He is a recipient of the the Franz Volhard Award of the German Society of Hypertension in 1992, the Young Investigator Award, Dr. C & F. Demuth Foundation, of the International Society of Hypertension (ISH) in 1996, the Franz Gross Science Award of the German Society of Hypertension in 2021. His main research interests include clinical pharmacology of cardiovascular drugs and clinical and experimental hypertension. He is a member of the Scientific Council of the European Society of Hypertension (ESH) since 2015. In the ESH, he had served as ESH Secretary from 2017 to 2019 and as president from 2019 to 2022. He was the Co-Chair of the 2023 ESH Hypertension Guidelines Task Force and the 2024 Clinical Practice Guidelines for the management of hypertension of the ESH. Professor Kreutz was awarded an honorary membership of the Polish Society and Hungarian Society of Hypertension in 2022 and 2024, respectively, and an honorary doctorate (honoris causa) from the School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece in 2022.

He has published more than 500 scientific articles and several book chapters related to hypertension and clinical pharmacology. His H-index is 73 (Google Scholar) and ScholarGPS

has placed him in the top 0.05% of all scholars worldwide in 2024.

Professor Kreutz is actual Editor of Blood Pressure and an editorial Board member of the Journal of Hypertension, Hypertension (AHA), Journal of Clinical Hypertension, and High Blood Pressure & Cardiovascular Prevention.